GW Pharma (GWPH) PT Lowered to $193 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Elemer Piros lowered the price target on GW Pharma (NASDAQ: GWPH) to $193.00 (from $211.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
